Strategic Capital Advisers’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Strategic Capital Advisers's LLY Position: Q2 2022 in Review
Strategic Capital Advisers increased its Eli Lilly (LLY) stake by 1.1% in Q2 2022, buying an estimated $46.5K and bringing the position to 14,214 shares worth $4.61M. The position accounts for 3.81% of the portfolio, ranked #4.
Strategic Capital Advisers first reported a position in LLY in Q4 2017 and has held it in 19 quarters since. 2,445 funds tracked by Wall St. Rank hold LLY as of Q2 2022.
- Strategic Capital Advisers held 14,214 shares of Eli Lilly worth $4.61M as of Q2 2022.
- Strategic Capital Advisers bought 155 Eli Lilly shares in Q2 2022, an estimated $46.5K.
- Eli Lilly made up 3.81% of Strategic Capital Advisers's portfolio in Q2 2022, its #4 holding.
- Strategic Capital Advisers first reported a position in Eli Lilly in Q4 2017 and has held it in 19 quarters since.
- 2,445 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2022.
Based on Strategic Capital Advisers's 13F filing for Q2 2022, filed 18 Jul 2022.